Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
Conditions:   Acute Myocardial Infarction;   Cardiogenic Shock Interventions:   Drug: Tocilizumab;   Drug: Dobutamine;   Drug: NaCl 0.9% Sponsors:   Rigshospitalet, Denmark;   Novo Nordisk A/S;   Simon Spies Fonden;   Helge Peetz og Verner Peetz og hustru Vilma Peetz Legat Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2022 Category: Research Source Type: clinical trials